ERBB2 and breast cancer: Breast cancer is a common cause for central nervous system (CNS) metastasis, diagnosed in 10–16% of patients [1], with higher rates of up to 30–50% among patients with human epidermal growth factor 2 (HER2) overexpression [2] or triple-negative disease [3].